HLA Antigens and Complement C4 Allotypes in Patients with Chronic Biologically False Positive (CBFP) Seroreactions for Syphilis: A Follow-Up Study of SLE Patients and CBFP Reactors

Abstract

We report a follow-up of our previous study of HLA markers in 118 unrelated patients: 49 with definite systemic lupus erythematosus (SLE) (group 1), 32 with definite or probable SLE and chronic biologically false positive (CBFP) seroreactions for syphilis (group 2), and 37 CBFP reactors (group 3). Definite SLE was confirmed in 28 (90.3%) of the patients in group 2, equally in HLA B8- and HLA B7-positive patients. Three of the CBFP reactors developed SLE, two (40%) out of five HLA B8-positive as compared to one (6.6%) out of 15 HLA By-positive CBFP reactors (P = 0.07). Fourteen patients died (groups 1 and 2). Eight of the 24 HLA B8-positive patients died in contrast to one of the 20 HLA B7-positive patients (P < 0.02).

Of the CBFP reactors, 70.9% had complement C4 null alleles as compared to 47.9% in controls (P = 0.05) and 50% had C4A null alleles as compared to 17.8% in controls (P < 0.05). C4B null alleles were found in 28.6% (28.6% in controls, P is not significant). The null alleles for C4A were not solely in a linkage disequilibrium with the HLA B8 DR3 haplotype. CBFP reactors with C4A null alleles had a higher risk of developing SLE, lupus-like disease or symptoms such as photosensitivity, cutaneous vasculitis and/or autoantibodies than did those with no C4A null alleles (P < 0.02).

Keywords

HLA and complement markers Antiphospholipid antibodies SLE CBFP reactors

Get full access to this article

View all access options for this article.

References

Awdeh EL , Ochs HD , Alper CA Genetic analysis of C4 deficiency. J Clin Invest 1981; 67: 260-3.

Schur PH Complement and lupus erythematosus. Arthritis Rheum 1982; 25:793-8.

Christiansen FT , Dawkins RL , Uko G. , McCluskey J. , Kay PH , Zilko PJ Complement allotyping in SLE: association with C4 A null. Aust NZ J Med 1983; 13:483-8.

Dawkins RL , Christiansen FT , Kay PH et al. Disease associations with complotypes, supratypes and haplotypes . Immunol Rev 1983; 70: 5-22.

Fielder Ahl , Walport MJ , Batchelor JR et al. Family study of the major histocompatibility complex in patients with systemic lupus erythematosus: importance of null alleles of C4 A and C4 B determining disease suspectibility. Br J Med 1983; 286: 425-8.

Walport MJ , Fielder Ahl , Batchelor JR Genetics of systemic lupus erythematosus. In: Panayi GS , David CS , eds. Immunogenetics. London: Butterworth , 1984: 157-76.

Hauptmann G. , Goetz J. , Uring-Lambert B. , Grosshans E.

Complement deficiences 2. The Fourth Component Progr

Allergy 1986; 39: 232-49.

Partanen J. , Koskimies S. , Johansson EA C4 null phenotypes among lupus erythematosus patients are predominantly result of deletions covering C4 and closely linked 21-hydroxylase A genes . J Med Genet 1988; 25: 387-91.

Morgan PB , Walport MJ Complement deficiency and disease. Overview. Immunology Today 1991; 12: 301-6.

10.

Hawkins BR , Rigby RJ , Dawkins RL , Richmond J. Immunogenetic factors in systemic lupus erythematosus. Arthritis Rheum 1979; 22: 1-94.

11.

Dawkins RL , Richmond J. , Witt C. et al. HLA in systemic lupus erythematosus: haplotypes linkage and specificity of lymphocytotoxic antibodies in relation to severity of disease. Tissue Antigens 1977; 10: 213.

12.

Bell BA , Maddison PJ Serologic subsets in systemic lupus erythematosus: an examination of autoantibodies in relationship to clinical features of disease and HLA antigens: Arthritis Rheum 1980; 23: 1268-73.

13.

Johansson EA , Koskimies S. , Tiilikainen A. , Lassus A. HLA antigens in patients with chronic biologically false positive seroreactions for syphilis and systemic lupus erythematosus . Arch Dermatol 1982 ; 272: 55-60.

14.

Partanen J. , Koskimies S. Human MCH class III genes, Bf and C4: polymorphism, complotypes and association with MHC class I genes in the Finnish population . Human Hered 1986; 36: 269-75.

15.

Johansson EA Clinical and factorial evaluation of 110 CBFP reactors. Acta Derm Venereol (Stockholm ) 1971; 51 (Suppl 65): 1-37.

16.

Jouhikainen T. , Julkunen H. , Vaarala O. et al. Antiphospholipid antibodies and thrombosis in systemic lupus erythematosus: comparison of three lupus anticoagulant assays and anticardiolipin ELISA in 188 patients. Blood Coag Fibrinol 1992; 3: 407-141.

17.

Harris EN , Boye ML , Mackworth-Young CG et al. Anticardiolipin antibodies: detection by radioimmunoassay and association with thrombosis in systemic lupus erythematosus. Lancet 1983; ii: 1211-4.

18.

Vaarala O. , Vaara M. , Palosuo T. Effective inhibition of cardiolipin binding antibodies in gram-negative infections by bacterial lipopolysaccharide. Scand J Immunol 1988; 28: 607-12.

19.

Awdeh EL , Alper CA Inherited structural polymorphism of the fourth component of human complement . Proc Natl Acad Sci USA 1980; 77: 3576-80.

20.

Moore JE , Lutz WB The natural history of systemic lupus erythematosus. An approach to its study through chronic biologic false positive reactors. J Chron Dis 1955; 1: 297-316.

21.

Koskela P. , Vaarala O. , Mäkitalo PR , Palosuo T. , Aho K. Significance of false positive syphilis reactions and anticardiolipin antibodies in a nationwide series of pregnant women. JRheumatol 1988; 15: 70-3.

22.

Thornton JG , Foote GA , Page CE , Clayden AD , Tovey Lad , Scott JS False positive results of tests for syphilis and outcome pregnancy: a retrospective case-control study. Br Med J 1987; 295: 355-6.

23.

Mackworth-Young C. , Chan J. , Harris N. et al. High incidence of anticardiolipin antibodies in relatives of patients with systemic lupus erythematosus. J Rheumatol 1987; 14: 723-6.

24.

Wilson WA , Perez MZ , Michalski JP , Armatis PE Cardiolipin antibodies and null alleles of C4 null in black Americans with systemic lupus erythematosus. J Rheumatol 1988; 15: 1768-72.

25.

Sturfelt G. , Truedsson L. , Johansen P. , Jonsson H. , Nived O. , Sjöholm G. Homozygous C4 deficiency in systemic lupus erythematosus: analysis of patients from a defined population. Clinical Genetics 1990; 38: 427-33.

26.

Agnello V. Lupus disease associated with hereditary and acquired deficiencies of complement . Springer Semin Immunopathol 1986; 9: 161-78.

27.

Schifferli JA , Yin CN , Peters K. The role of complement and its receptor in the elimination of immune complexes. New Engl JMed 1986; 315: 488-95.

28.

Schifferli JA , Steiger G. , Paccaud JP , Sjöblom AG , Hauptmann G. Difference in the biological properties of the two forms of the fourth component of human complement (C4). Clin Exp Immunol 1986; 63: 473-7.

29.

Lewkonia RM The clinical genetics of lupus. Lupus 1992; 1: 55-62.